Novel thiophene derivatives as sphingosine-l-phosphate-1 receptor agonists

Details for Australian Patent Application No. 2006226020 (hide)

Owner Actelion Pharmaceuticals Ltd.

Inventors Weller, Thomas; Velker, Jorg; Nayler, Oliver; Bolli, Martin; Lehmann, David; Mathys, Boris; Mueller, Claus

Agent A J Park

Pub. Number AU-A-2006226020

PCT Pub. Number WO2006/100633

Priority PCT/ EP2005/003070 23.03.05 EP

Filing date 20 March 2006

Wipo publication date 28 September 2006

International Classifications

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

8 November 2007 PCT application entered the National Phase

  PCT publication WO2006/100633 Priority application(s): WO2006/100633

18 October 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226022-Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists

2006226018-Hydrogenated benzo (C) thiophene derivatives as immunomodulators